CellCentric

Summary active Updated May 7, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Cambridge, UK
Founded 2003
Latest Stage Series D
Total Raised $220M+
Website https://www.cellcentric.com/
Sector
biotech oncology drug-development healthcare life-sciences

Investors

Venrock series-d (2026)

Founders

Will West CEO & Co-Founder
Azim Surani Co-Founder

About

CellCentric is a Cambridge, UK-based clinical-stage biotech (with an office in Boston) developing inobrodib, an oral small-molecule p300/CBP inhibitor for advanced blood cancers, including multiple myeloma 12. The company was founded in 2003 by Will West (CEO) and Cambridge geneticist Azim Surani 4. On May 6, 2026, CellCentric announced an oversubscribed $220M Series D led by Venrock Healthcare Capital Partners — Europe’s largest private biotech fundraise of 2026 to date 13. Proceeds will fund the Phase 2 DOMMINO-1 study and the launch of the global Phase 3 DOMMINO-2 trial in the second half of 2026 1.

Funding History

Date Round Amount Lead Co-investors
2026-05-06 Series D $220M Venrock Healthcare Capital Partners Fidelity Management & Research Company, Sofinnova Partners, HBM Healthcare, RA Capital Management, Forbion, Pfizer, Avego BioScience Capital, American Cancer Society BrightEdge 123

What Investors Say

No independently sourced investor quotes found.

What Founders Say

No independently sourced founder quotes found.

Sources

  1. BioSpace press release, “CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma,” May 6, 2026. https://www.biospace.com/press-releases/cellcentric-announces-oversubscribed-220-million-series-d-financing-to-advance-pivotal-trials-of-inobrodib-in-multiple-myeloma↩↩↩↩

  2. BioPharma Dive, “CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine,” May 6, 2026. https://www.biopharmadive.com/news/cellcentric-series-d-multiple-myeloma-inobrodib/819348/↩↩

  3. BioSpace, “CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026,” May 6, 2026. https://www.biospace.com/business/cellcentric-secures-220m-in-europes-biggest-private-biotech-fundraise-of-202↩↩

  4. CellCentric team page, “Will West,” accessed May 2026. https://www.cellcentric.com/team/will-west/↩